RVL Pharmaceuticals (RVLPQ) Financial Statements

311 Followers

RVL Pharmaceuticals Financial Overview

RVL Pharmaceuticals's market cap is currently $111.00. The company's EPS TTM is $; its P/E ratio is -0.05; RVL Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Income Statement
Total Revenue	$ 49.72M	$ 17.50M	$ 27.76M	$ 240.03M	$ 263.70M
Gross Profit	$ 40.27M	$ 13.88M	$ 24.47M	$ 128.40M	$ 123.62M
Operating Income	$ -45.68M	$ -80.51M	$ -61.74M	$ 3.94M	$ -98.54M
EBITDA	$ -36.19M	$ -73.67M	$ -69.72M	$ -49.80M	$ -664.39M
Net Income	$ -51.69M	$ -82.85M	$ -89.01M	$ -270.90M	$ -109.68M
Balance Sheet
Cash & Short-Term Investments	$ 44.54M	$ 43.51M	$ 114.05M	$ 95.86M	$ 70.83M
Total Assets	$ 128.51M	$ 144.67M	$ 370.95M	$ 463.25M	$ 795.62M
Total Debt	$ 57.49M	$ 47.65M	$ 221.62M	$ 273.30M	$ 268.83M
Net Debt	$ 12.95M	$ 7.20M	$ 107.56M	$ 177.43M	$ 198.00M
Total Liabilities	$ 77.42M	$ 67.94M	$ 277.09M	$ 348.55M	$ 411.78M
Stockholders' Equity	$ 51.09M	$ 76.73M	$ 93.86M	$ 114.71M	$ 383.85M
Cash Flow
Free Cash Flow	$ -38.56M	$ -56.51M	$ 14.46M	$ 29.53M	$ 33.41M
Operating Cash Flow	$ -37.81M	$ -54.73M	$ 17.59M	$ 33.57M	$ 37.56M
Investing Cash Flow	$ 126.00K	$ 116.45M	$ -3.08M	$ -4.02M	$ -4.13M
Financing Cash Flow	$ 41.78M	$ -135.33M	$ 3.68M	$ -4.69M	$ 3.60M

Currency in USD

RVL Pharmaceuticals Earnings and Revenue History

Income Statement >

RVL Pharmaceuticals Debt to Assets

Balance Sheet >

RVL Pharmaceuticals Cash Flow

Cash Flow >

RVL Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >